Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2025 Filed Mar 14, 2025 21:28 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 400 | $63.33 | $25,332.00 |
DisclosureSEC source: 0001938861-25-000008 · wk-form4_1741987671.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,545 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:28 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
SaleCommon Stock | 1,000 | $60.86 | $60,860.00 |
DisclosureSEC source: 0001946439-25-000008 · wk-form4_1741652880.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024. Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 21:22 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 2,874 | $60.62 | $174,221.88 |
DisclosureSEC source: 0001846487-25-000006 · wk-form4_1741987349.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,317 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 21:20 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 17,060 | $60.62 | $1,034,177.20 |
DisclosureSEC source: 0001822629-25-000006 · wk-form4_1741987242.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,634 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 21:19 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 3,314 | $60.62 | $200,894.68 |
DisclosureSEC source: 0001846478-25-000009 · wk-form4_1741987175.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,778 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 21:17 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 5,150 | $60.62 | $312,193.00 |
DisclosureSEC source: 0001674236-25-000006 · wk-form4_1741987072.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,073 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC |
Gutwerg OriSVP, GENERICS
|
Exercise / conversionStock Option (right to buy) · Derivative | 300 | $31.49 Strike: $31.49 | $9,447.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · derivative · entry 4 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,204 Underlying: Common Stock · 300 shares Expires 2031-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 5,084 | $60.00 | $305,040.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · nonDerivative · entry 3 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,092 F1 · price: The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 300 | $60.03 | $18,009.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,176 Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC |
Gutwerg OriSVP, GENERICS
|
Exercise / conversionCommon Stock | 300 | $31.49 | $9,447.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:15 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
Tax withholdingCommon Stock | 627 | $61.89 | $38,805.03 |
DisclosureSEC source: 0001507496-25-000004 · wk-form4_1741126494.xml · nonDerivative · entry 1 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,465 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,171 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:12 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,275 | $61.89 | $78,909.75 |
DisclosureSEC source: 0001846487-25-000004 · wk-form4_1741126332.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,191 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:10 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 12,216 | $61.89 | $756,048.24 |
DisclosureSEC source: 0001822629-25-000004 · wk-form4_1741126197.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,694 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 23,882 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:07 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,570 | $61.89 | $97,167.30 |
DisclosureSEC source: 0001846478-25-000005 · wk-form4_1741126058.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,176 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:06 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
Tax withholdingCommon Stock | 1,099 | $61.89 | $68,017.11 |
DisclosureSEC source: 0001946439-25-000006 · wk-form4_1741125961.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,525 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:04 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
Tax withholdingCommon Stock | 1,099 | $61.89 | $68,017.11 |
DisclosureSEC source: 0001938861-25-000006 · wk-form4_1741125873.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,945 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:03 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 1,861 | $61.89 | $115,177.29 |
DisclosureSEC source: 0001674236-25-000004 · wk-form4_1741125785.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,223 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:33 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
SaleCommon Stock | 1,000 | $60.20 | $60,200.00 |
DisclosureSEC source: 0001946439-25-000004 · wk-form4_1740432806.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 01:17 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,184 | $58.92 | $69,761.28 |
DisclosureSEC source: 0001846487-25-000002 · wk-form4_1739927844.xml · nonDerivative · entry 4 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,466 F4 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 01:15 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,167 | $58.92 | $68,759.64 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 4 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,746 F4 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,227 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:19 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
Tax withholdingCommon Stock | 582 | $58.92 | $34,291.44 |
DisclosureSEC source: 0001507496-25-000002 · wk-form4_1739927941.xml · nonDerivative · entry 3 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,092 F4 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:17 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,473 | $58.92 | $86,789.16 |
DisclosureSEC source: 0001846487-25-000002 · wk-form4_1739927844.xml · nonDerivative · entry 3 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,650 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:16 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 7,799 | $58.92 | $459,517.08 |
DisclosureSEC source: 0001822629-25-000002 · wk-form4_1739927772.xml · nonDerivative · entry 3 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,910 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,132 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:15 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,426 | $58.92 | $84,019.92 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 3 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,913 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,690 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:13 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
Tax withholdingCommon Stock | 1,196 | $58.92 | $70,468.32 |
DisclosureSEC source: 0001946439-25-000002 · wk-form4_1739927578.xml · nonDerivative · entry 3 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,624 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,019 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:12 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
Tax withholdingCommon Stock | 1,434 | $58.92 | $84,491.28 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 4 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,044 F4 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,690 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:11 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 1,730 | $58.92 | $101,931.60 |
DisclosureSEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,084 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 01:12 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 400 | $59.54 | $23,816.00 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 3 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,478 F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:19 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
GrantCommon Stock | 5,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001507496-25-000002 · wk-form4_1739927941.xml · nonDerivative · entry 2 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,674 F3 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:19 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
GrantCommon Stock | 7,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001507496-25-000002 · wk-form4_1739927941.xml · nonDerivative · entry 1 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,452 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. F2 · balance_after: Includes 449 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:19 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
GrantCommon Stock | 9,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001870913-25-000002 · wk-form4_1739927992.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,588 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:19 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
GrantCommon Stock | 14,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001870913-25-000002 · wk-form4_1739927992.xml · nonDerivative · entry 1 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,014 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:17 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 16,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001846487-25-000002 · wk-form4_1739927844.xml · nonDerivative · entry 2 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,123 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:17 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 24,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001846487-25-000002 · wk-form4_1739927844.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,585 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:16 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 60,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001822629-25-000002 · wk-form4_1739927772.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 522,709 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:16 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 91,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001822629-25-000002 · wk-form4_1739927772.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,777 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:15 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 10,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,339 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:15 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 15,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,895 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:14 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
GrantCommon Stock | 9,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001871002-25-000002 · wk-form4_1739927639.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,615 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:14 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
GrantCommon Stock | 14,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001871002-25-000002 · wk-form4_1739927639.xml · nonDerivative · entry 1 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,041 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:13 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 8,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001946439-25-000002 · wk-form4_1739927578.xml · nonDerivative · entry 2 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,820 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:13 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 13,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001946439-25-000002 · wk-form4_1739927578.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,116 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:12 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 11,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,878 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:12 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 16,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,562 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:11 UTC |
CAREY STEPHEN P.SVP & CFO
|
GrantCommon Stock | 16,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,814 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:11 UTC |
CAREY STEPHEN P.SVP & CFO
|
GrantCommon Stock | 24,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,276 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 21:15 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 400 | $53.92 | $21,568.00 |
DisclosureSEC source: 0001938861-25-000002 · wk-form4_1736802904.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,588 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 22:59 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 7,500 | $55.79 | $418,425.00 |
DisclosureSEC source: 0001674236-24-000015 · wk-form4_1734562739.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,468 F1 · price: The shares were sold in multiple trades at prices ranging from $55.29 to $56.30. The price reported above reflects the weighted average sales price. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 21:20 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $56.24 | $14,060.00 |
DisclosureSEC source: 0001938861-24-000032 · wk-form4_1734384022.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,988 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 22:08 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
SaleCommon Stock | 1,000 | $60.00 | $60,000.00 |
DisclosureSEC source: 0001946439-24-000008 · wk-form4_1734041311.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,059 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.